PHASQ Insider Trading - PhaseBio Pharmaceuticals, Inc.

İçeriden Öğrenenlerin Hisseleri

12.488.536 shares

İçeriden Öğrenenlerin Eğilim Skoru

İçeriden Öğrenenlerin Eğilim Skoru, kurumsal içeriden öğrenenler tarafından satın alınan şirketleri bulur.

En yüksek düzeyde içeriden öğrenen birikimine sahip şirketleri tanımlayan karmaşık, çok faktörlü kantitatif bir modelin sonucudur. Skorlama modeli, önceki 90 günde satın alan içeriden öğrenenlerin net sayısının, float yüzde olarak satın alınan toplam hisselerin ve içeriden öğrenenlerin sahip olduğu toplam hisselerin bir kombinasyonunu kullanıyor. Sayı 0 ila 100 arasında değişir; daha yüksek sayılar, emsallerine göre daha yüksek bir birikim düzeyine işaret eder ve 50 ortalamadır.

Güncelleme Sıklığı: Günlük

En yüksek içeriden öğrenen birikimine sahip şirketlerin listesini sağlayan İçeriden Öğrenenlerin En Çok Tercih Ettiklerine bakınız.

Sıralamada En Yüksekteki Hisse Senetlerini Görün

Şirket Yetkilisi Eğilim Skoru

Şirket Yetkilisi Eğilim Skoru, Kurumsal Şirket Yetkilileri tarafından satın alınan şirketleri bulur.

Tanım gereği Kurumsal Yetkililer, Kurumsal İçeriden Öğrenenlerdir, ancak diğer İçeriden Öğrenenlerin (% 10 Hissedarlar ve Yönetim Kurulu Üyeleri) aksine, Şirket Yetkilileri günlük olarak şirket için çalışırlar ve alım satım yaparken kendi paralarını kullanırlar . (%10 Hissedarlar ve Yönetim Kurulu Üyeleri genellikle başkalarının parasını yöneten fon yöneticileridir.) Bu sebeple, Şirket Yetkilileri tarafından yapılan içeriden öğrenenlerin ticareti çok daha önemlidir ve uygun şekilde ele alınmalıdır.

İçeriden Öğrenenlerin Eğilim Skoru gibi, Şirket Yetkilileri Eğilim Skoru en yüksek düzeyde şirket yetkilisi birikimine sahip şirketleri belirleyen gelişmiş, çok faktörlü kantitatif bir modelin sonucudur.

Güncelleme Sıklığı: Günlük

En yüksek içeriden bilgi eğilimine sahip şirketlerin listesini sağlayan İçeriden Öğrenenlerin En Çok Tercih Ettiklerine bakınız.

Sıralamada En Yüksekteki Hisse Senetlerini Görün

Anahtar İçeriden Öğrenen Metrikleri

Bu kart, şirketin çeşitli içeriden öğrenilen ölçümlere kıyasla nasıl sıralandığını gösterir. Yüzdelik sıralama, bu şirketin ABD pazarındaki diğer şirketlerle nasıl karşılaştırıldığını gösterir. Daha yüksek sıralamalar daha iyi durumların göstergesidir.

Örneğin, içeriden öğrenen alımlarının olumlu bir gösterge olduğu genel olarak kabul edilir, bu sebeple içeriden öğrenenlerin alımının daha yüksek olduğu şirketler, içeriden satın alan (hatta içeriden öğrenenlerin satışı) daha az olan şirketlere göre daha üst sıralarda yer alır.

Alım Yapan İçeriden Öğrenen Net Sayısı (Sıra)

N/A

Alım Yapan İçeriden Öğrenen Net Sayısı, alım yapan içeriden öğrenenlerin toplam sayısından son 90 gün içinde satış yapan içeriden öğrenenlerin toplam sayısı çıkarılarak elde edilir. Yüzdelik sıralama burada gösterilir (%0 ile %100 arası).

İçeriden Öğrenenler Tarafından Satın Alınan Float Yüzdesi (Sıra)

N/A

İçerden Öğrenenler Tarafından Satın Alınan Float Yüzdesi, içeriden öğrenenler tarafından satın alınan toplam hisse sayısından, son 90 gün içinde içeriden öğrenenler tarafından satılan toplam hisse sayısı çıkarılarak elde edilen toplam floata bölünür ve 100 ile çarpılır.

İçeriden Öğrenenlerin Ticareti Tablosu

PhaseBio Pharmaceuticals, Inc. içeriden öğrenenlerin ticareti aşağıdaki grafikte gösterilmektedir. İçeriden öğrenenler bir şirketteki yetkililer, yöneticiler veya önemli yatırımcılardır. Genel olarak, içeriden öğrenenlerin maddi, kamuya açıklanmamış bilgilere dayanarak şirketlerinde alım satım yapması genellikle yasa dışıdır. Bu onların kendi şirketlerinde herhangi bir işlem yapmalarının yasa dışı olduğu anlamına gelmez. Ancak tüm işlemleri Form 4 aracılığıyla SECye bildirilmesi gerekir.

İçeriden Öğrenenlerin Listesi ve Kârlılık Metrikleri

Bu tablo bilindik içeriden öğrenenlerin listesini gösterir ve SECye bildirilen dosyalardan otomatik olarak oluşturulur. İsimlere ek olarak, en son unvana ve yönetici, yetkili veya %10luk sahiplik tanımına ek olarak, açıklanan en son varlıkları da sağlıyoruz. Ek olarak, mümkün olduğunda içeriden öğrenen için geçmiş ticari performansı da sağlıyoruz. Geçmiş ticari performans, içeriden öğrenenlerin yaptığı gerçek açık piyasa satın alma işlemlerinin performansının ağırlıklı ortalamasıdır. Bunun nasıl hesaplandığı hakkında daha fazla bilgi için bu YouTube web seminerini izleyiniz.

See our leaderboard of most profitable insider traders.

İçeriden Öğrenen	Ort Kâr (%)	Sahibi Olan Hisseler	Bölünmüş Düzeltilmiş

Report errors via our new Insider Auditing Tool

İçeriden Öğrenenlerin Alımlarının Takip Kayıtları - Kısa Vadeli Kâr Analizi

Bu bölümde, PHASQ / PhaseBio Pharmaceuticals, Inc. yılında yapılmış her planlanmamış, açık piyasada içeriden öğrenlenlerin satın almalarının kârlılığını analiz ediyoruz. Bu analiz, içeriden öğrenen kişinin sürekli olarak anormal getiriler sağlayıp sağlamadığını ve takip edilmeye değer olup olmadığını anlamaya yardımcı olur. Bu analiz her işlemin ardından bir yıl süreyle geçerlidir ve sonuçlar teoriktir .

Aşağıdaki tablo, otomatik ticaret planının parçası olmayan en son açık piyasa alımlarını göstermektedir.

İşlem Tarihi	İçeride Öğrenen	Bildirilmiş Hisseler	Bildirilmiş Fiyat	Düzeltilmiş Hisseler	Düzeltilmiş Fiyat	Maliyet Esası	Günler Maks	Fiyat Maks	Maks Kâr ($)	Maks Getiri (%)
2021-08-18	Thorp Clay	10.000	3,0000	10.000	3,0000	30.000	76	4.05	10.500	35,00
2021-08-18	Hutson Nancy J	3.000	3,0800	3.000	3,0800	9.240
2020-12-03	HARRIGAN EDMUND	6.000	4,1200	6.000	4,1200	24.720
2020-11-24	Thorp Clay	2.000	3,5000	2.000	3,5000	7.000
2020-11-23	Thorp Clay	3.000	3,6700	3.000	3,6700	11.010
2018-12-17	Hutson Nancy J	1.000	4,4600	1.000	4,4600	4.460
2018-12-13	Ballance David James	1.000	3,9400	1.000	3,9400	3.940
2018-12-13	Mow Jonathan P	1.000	3,6900	1.000	3,6900	3.690
2018-12-11	York Michael	1.500	3,8800	1.500	3,8800	5.820

Düzeltilmiş Fiyat bölünmüş olarak düzeltilmiş fiyattır. Düzeltilmiş Hisseler bölünmüş olarak düzeltilmiş hisselerdir.

PHASQ / PhaseBio Pharmaceuticals, Inc. Insider Trades

İçeriden Öğrenen Satışlarının Takip Kayıtları - Kısa Vadeli Zarar Analizi

Bu bölümde, PHASQ / PhaseBio Pharmaceuticals, Inc. yılında yapılan her planlanmamış, açık piyasa içeriden öğrenilen satışın kısa vadeli zarardan kaçınma miktarını analiz ediyoruz. Tutarlı bir kayıptan kaçınma modeli, gelecekteki satış işlemlerinin fiyattaki düşüşleri öngörebileceğini düşündürebilir. Bu analiz her işlemin ardından bir yıl süreyle geçerlidir ve sonuçlar teoriktir .

Aşağıdaki tablo, otomatik ticaret planının parçası olmayan en son açık piyasa satışlarını göstermektedir.

İşlem Tarihi	İçeride Öğrenen	Bildirilmiş Hisseler	Bildirilmiş Fiyat	Düzeltilmiş Hisseler	Düzeltilmiş Fiyat	Maliyet Esası	Günler Min	Fiyat Min	Maks Kayıp Kaçınılan ($)	Maks Kayıp Kaçınılan (%)
2022-10-25	NEW ENTERPRISE ASSOCIATES 13 LP	1.784.109	0,1470	1.784.109	0,1470	262.264	8	0.0701	-137.198	-52,31
2021-05-20	Burkhardt Glen	3.811	3,2900	3.811	3,2900	12.538
2020-11-23	Burkhardt Glen	3.497	3,4500	3.497	3,4500	12.065

Düzeltilmiş Fiyat bölünmüş olarak düzeltilmiş fiyattır. Düzeltilmiş Hisseler bölünmüş olarak düzeltilmiş hisselerdir.

İşlem Geçmişi

Tam işlem geçmişini görmek için bağlantı simgesine tıklayın. 10b5-1 otomatik işlem planı kapsamında bildirilen işlemlerin 10b-5 ile işaretli sütununda X işareti bulunacaktır.

Dosya Tarih	Ticaret Tarihi	Form	İçeriden Öğrenenler	Ticker	Menkul Kıymet Başlığı	Kod	Doğrudan	İşleme Koyma Fiyatı	Birim Fiyatı	Birimler Değiştirildi	Değer Değiştirildi (1K)	Geriye Kalan Opsiyonlar	Geriye Kalan Hisseler
2023-05-19	2023-05-19	4	Humphries William D.	PHAS	Common Stock	M - Exercise	D			2.538			2.538
2023-05-19	2023-05-19	4	Thorp Clay	PHAS	Common Stock	M - Exercise	D			3.750			36.693
2023-05-19	2023-05-19	4	van den Broek Richard	PHAS	Common Stock	A - Award	D			3.750			0
2023-05-19	2023-05-19	4	Loewy Caroline M	PHAS	Common Stock	M - Exercise	D			3.750			3.750
2023-05-19	2023-05-19	4	Sapir Alex	PHAS	Common Stock	M - Exercise	D			3.750			3.750
2023-05-19	2023-05-19	4	HARRIGAN EDMUND	PHAS	Common Stock	M - Exercise	D			3.750			9.750
2023-05-19	2023-05-19	4	Hutson Nancy J	PHAS	Common Stock	M - Exercise	D			3.750			37.510
2022-10-26	2022-10-25	4	NEW ENTERPRISE ASSOCIATES 13 LP	PHAS	Common Stock	S - Sale	D		0,1470	-1.784.109	-262		4.857.525
2022-05-24	2022-05-20	4	Arnold Susan Elizabeth	PHAS	Common Stock	A - Award	D		0,6813	10.917	7		41.236
2022-05-24	2022-05-20	4	Mow Jonathan P	PHAS	Common Stock	A - Award	D		0,6813	10.918	7		132.502
2022-05-24	2022-05-20	4	Hanson Kristopher	PHAS	Common Stock	A - Award	D		0,6813	4.831	3		8.463
2022-05-24	2022-05-20	4	Birchall Jonathan	PHAS	Common Stock	A - Award	D		0,6813	20.000	14		20.000
2022-05-24	2022-05-23	4	Burkhardt Glen	PHAS	Common Stock	S - Sale	D		0,7900	-11.248	-9		0
2022-05-24	2022-05-20	4	Burkhardt Glen	PHAS	Common Stock	A - Award	D		0,6813	11.248	8		11.248
2022-05-24	2022-05-20	4	Sharp John P	PHAS	Common Stock	A - Award	D		0,6813	6.026	4		65.767
2022-05-20	2021-08-18	4/A	Hutson Nancy J Held in an individual retirement account for the benefit of the Reporting Person	PHAS	Common Stock	P - Purchase	I		3,0800	3.000	9		4.000
2022-05-20	2022-05-19	4	Thorp Clay	PHAS	Restricted Stock Units	A - Award	D			3.750		3.750
2022-05-20	2022-05-19	4	Thorp Clay	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0,84		17.500		17.500
2022-05-20	2022-05-19	4	Humphries William D.	PHAS	Restricted Stock Units	A - Award	D			3.750		3.750
2022-05-20	2022-05-19	4	Humphries William D.	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0,84		17.500		17.500
2022-05-20	2022-05-19	4	Loewy Caroline M	PHAS	Restricted Stock Units	A - Award	D			3.750		3.750
2022-05-20	2022-05-19	4	Loewy Caroline M	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0,84		17.500		17.500
2022-05-20	2022-05-19	4	Sapir Alex	PHAS	Restricted Stock Units	A - Award	D			3.750		3.750
2022-05-20	2022-05-19	4	Sapir Alex	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0,84		17.500		17.500
2022-05-20	2022-05-19	4	Hutson Nancy J	PHAS	Restricted Stock Units	A - Award	D			3.750		3.750
2022-05-20	2022-05-19	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0,84		17.500		17.500
2022-05-20	2022-05-19	4	van den Broek Richard	PHAS	Restricted Stock Units	A - Award	D			3.750		3.750
2022-05-20	2022-05-19	4	van den Broek Richard	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0,84		17.500		17.500
2022-05-20	2022-05-19	4	HARRIGAN EDMUND	PHAS	Restricted Stock Units	A - Award	D			3.750		3.750
2022-05-20	2022-05-19	4	HARRIGAN EDMUND	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0,84		17.500		17.500
2022-02-28	2022-02-24	4	Burkhardt Glen	PHAS	Employee Stock Option (right to buy)	A - Award	D	1,13		87.500		87.500
2022-02-28	2022-02-24	4	Burkhardt Glen	PHAS	Restricted Stock Unit	A - Award	D			18.750		18.750
2022-02-28	2022-02-24	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	A - Award	D	1,13		115.500		115.500
2022-02-28	2022-02-24	4	Sharp John P	PHAS	Restricted Stock Unit	A - Award	D			24.750		24.750
2022-02-28	2022-02-24	4	Birchall Jonathan	PHAS	Employee Stock Option (right to buy)	A - Award	D	1,13		52.500		52.500
2022-02-28	2022-02-24	4	Birchall Jonathan	PHAS	Restricted Stock Unit	A - Award	D			11.250		11.250
2022-02-28	2022-02-24	4	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	A - Award	D	1,13		87.500		87.500
2022-02-28	2022-02-24	4	Arnold Susan Elizabeth	PHAS	Restricted Stock Unit	A - Award	D			18.750		18.750
2022-02-28	2022-02-24	4	Lee John Sang	PHAS	Employee Stock Option (right to buy)	A - Award	D	1,13		115.500		115.500
2022-02-28	2022-02-24	4	Lee John Sang	PHAS	Restricted Stock Unit	A - Award	D			24.750		24.750
2022-02-28	2022-02-24	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	A - Award	D	1,13		385.000		385.000
2022-02-28	2022-02-24	4	Mow Jonathan P	PHAS	Restricted Stock Unit	A - Award	D			82.500		82.500
2022-02-28	2022-02-24	4	Hanson Kristopher	PHAS	Employee Stock Option (right to buy)	A - Award	D	1,13		87.500		87.500
2022-02-28	2022-02-24	4	Hanson Kristopher	PHAS	Restricted Stock Unit	A - Award	D			18.750		18.750
2021-11-23	2021-11-19	4	Arnold Susan Elizabeth	PHAS	Common Stock	A - Award	D		2,0100	2.559	5		30.319
2021-11-23	2021-11-19	4	Mow Jonathan P	PHAS	Common Stock	A - Award	D		2,0100	5.623	11		172.473
2021-11-23	2021-11-19	4	Sharp John P	PHAS	Common Stock	A - Award	D		2,0100	2.017	4		59.741
2021-11-23	2021-11-19	4	Hanson Kristopher	PHAS	Common Stock	A - Award	D		2,0100	1.545	3		3.632
2021-11-23	2021-11-19	4	Burkhardt Glen	PHAS	Common Stock	S - Sale	D		2,3700	-5.766	-14		0
2021-11-23	2021-11-19	4	Burkhardt Glen	PHAS	Common Stock	A - Award	D		2,0100	5.766	12		5.766
2021-11-09	2021-11-08	4	Birchall Jonathan	PHAS	Employee Stock Option (right to buy)	A - Award	D	3,37	3,3700	250.000	842	250.000
2021-11-08	2021-11-08	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	M - Exercise	D	3,15	3,1500	-7.400	-23	0
2021-11-08	2021-11-08	4	Hutson Nancy J	PHAS	Common Stock	M - Exercise	D		3,1500	7.400	23		33.760
2021-11-08	2021-11-05	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	M - Exercise	D	3,15	3,1500	-1.500	-5	7.400
2021-11-08	2021-11-05	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	M - Exercise	D	2,26	2,2600	-24.860	-56	2.256
2021-11-08	2021-11-05	4	Hutson Nancy J	PHAS	Common Stock	M - Exercise	D		3,1500	1.500	5		26.360
2021-11-08	2021-11-05	4	Hutson Nancy J	PHAS	Common Stock	M - Exercise	D		2,2600	24.860	56		24.860
2021-11-03	2021-11-03	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,68	1,6800	-7.500	-13	90.582
2021-11-03	2021-11-03	4	Sharp John P	PHAS	Common Stock	M - Exercise	D		1,6800	7.500	13		57.724
2021-11-03	2021-11-03	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,24	1,2400	-20.000	-25	108.767
2021-11-03	2021-11-03	4	Mow Jonathan P	PHAS	Common Stock	M - Exercise	D		1,2400	20.000	25		166.850
2021-09-15	2021-09-14	4	Humphries William D.	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	2,80		28.000		28.000
2021-09-03	2021-07-12	4/A	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,74		-4.519		0
2021-09-03	2021-07-12	4/A	Arnold Susan Elizabeth	PHAS	Common Stock	M - Exercise	D		1,7400	4.519	8		27.760
2021-09-03	2021-08-03	4/A	Sharp John P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,68		-7.500		98.082
2021-09-03	2021-08-03	4/A	Sharp John P	PHAS	Common Stock	M - Exercise	D		1,6800	7.500	13		50.224
2021-08-30	2021-08-27	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,24		-20.000		128.767
2021-08-30	2021-08-27	4	Mow Jonathan P	PHAS	Common Stock	M - Exercise	D		1,2400	20.000	25		146.850
2021-08-19	2021-08-18	4	Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person	PHAS	Common Stock	P - Purchase	I		3,0800	3.000	9		4.000
2021-08-18	2021-08-18	4	Thorp Clay	PHAS	Common Stock	P - Purchase	D		3,0000	10.000	30		32.943
2021-08-04	2021-08-03	4	Sharp John P	PHAS	Common Stock	A - Award	D		1,6800	7.500	13		50.224
2021-07-14	2021-07-12	4	Arnold Susan Elizabeth	PHAS	Common Stock	A - Award	D		1,7400	4.519	8		27.760
2021-06-04	2021-06-03	4	van den Broek Richard	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,53		14.000		14.000
2021-06-04	2021-06-03	4	Sapir Alex	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,53		14.000		14.000
2021-06-04	2021-06-03	4	HARRIGAN EDMUND	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,53		14.000		14.000
2021-06-04	2021-06-03	4	Klein Peter Justin	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,53		14.000		14.000
2021-06-04	2021-06-03	4	Loewy Caroline M	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,53		14.000		14.000
2021-06-04	2021-06-03	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,53		14.000		14.000
2021-06-04	2021-06-03	4	Thorp Clay	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,53		14.000		14.000
2021-05-24	2021-05-20	4	Arnold Susan Elizabeth	PHAS	Common Stock	A - Award	D		2,8000	5.257	15		23.241
2021-05-24	2021-05-20	4	York Michael	PHAS	Common Stock	A - Award	D		2,8000	2.897	8		7.059
2021-05-24	2021-05-20	4	Hanson Kristopher	PHAS	Common Stock	A - Award	D		2,8000	1.088	3		2.087
2021-05-24	2021-05-20	4	Mow Jonathan P	PHAS	Common Stock	A - Award	D		2,8000	3.964	11		126.850
2021-05-24	2021-05-20	4	Burkhardt Glen	PHAS	Common Stock	S - Sale	D		3,2900	-3.811	-13		0
2021-05-24	2021-05-20	4	Burkhardt Glen	PHAS	Common Stock	A - Award	D		2,8000	3.811	11		3.811
2021-05-24	2021-05-20	4	Sharp John P	PHAS	Common Stock	A - Award	D		2,8000	1.419	4		42.724
2021-02-09	2021-02-05	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	A - Award	D	4,31		234.000		234.000
2021-02-09	2021-02-05	4	Hanson Kristopher	PHAS	Employee Stock Option (right to buy)	A - Award	D	4,31		36.000		36.000
2021-02-09	2021-02-05	4	York Michael	PHAS	Employee Stock Option (right to buy)	A - Award	D	4,31		36.000		36.000
2021-02-09	2021-02-05	4	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	A - Award	D	4,31		36.000		36.000
2021-02-09	2021-02-05	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	A - Award	D	4,31		76.500		76.500
2021-02-09	2021-02-05	4	Lee John Sang	PHAS	Employee Stock Option (right to buy)	A - Award	D	4,31		76.500		76.500
2021-02-09	2021-02-05	4	Burkhardt Glen	PHAS	Employee Stock Option (right to buy)	A - Award	D	4,31		36.000		36.000
2020-12-04	2020-12-03	4	HARRIGAN EDMUND	PHAS	Common Stock	P - Purchase	D		4,1200	6.000	25		6.000
2020-11-24	2020-11-24	4	Thorp Clay	PHAS	Common Stock	P - Purchase	D		3,5000	2.000	7		22.943
2020-11-24	2020-11-23	4	Thorp Clay	PHAS	Common Stock	P - Purchase	D		3,6700	3.000	11		20.943
2020-11-23	2020-11-20	4	Sharp John P	PHAS	Common Stock	A - Award	D		3,0000	1.305	4		41.305
2020-11-23	2020-11-20	4	Hanson Kristopher	PHAS	Common Stock	A - Award	D		3,0000	999	3		999
2020-11-23	2020-11-20	4	York Michael	PHAS	Common Stock	A - Award	D		3,0000	2.662	8		4.162
2020-11-23	2020-11-20	4	Ballance David James	PHAS	Common Stock	A - Award	D		3,0000	919	3		8.519
2020-11-23	2020-11-20	4	Mow Jonathan P	PHAS	Common Stock	A - Award	D		3,0000	3.643	11		122.886
2020-11-23	2020-11-20	4	Arnold Susan Elizabeth	PHAS	Common Stock	A - Award	D		3,0000	4.832	14		17.984
2020-11-23	2020-11-23	4	Burkhardt Glen	PHAS	Common Stock	S - Sale	D		3,4500	-3.497	-12		0
2020-11-23	2020-11-20	4	Burkhardt Glen	PHAS	Common Stock	A - Award	D		3,0000	3.497	10		3.497
2020-11-18	2020-11-16	4	Thorp Clay By Catalysta Ventures, LLC	PHAS	Common Stock	J - Other	I			10.586			15.432
2020-11-18	2020-11-16	4	Thorp Clay	PHAS	Common Stock	J - Other	D			2.144			17.943
2020-11-18	2020-11-16	4	Thorp Clay By Hatteras Venture Partners I, LP	PHAS	Common Stock	J - Other	I			-52.397			0
2020-10-05	2020-10-01	4	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,15	1,1500	-5.423	-6	0
2020-10-05	2020-10-01	4	Arnold Susan Elizabeth	PHAS	Common Stock	M - Exercise	D		1,1500	5.423	6		13.152
2020-10-05	2020-02-27	4	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,15	1,1500	-5.423	-6	0
2020-10-05	2020-02-27	4	Arnold Susan Elizabeth	PHAS	Common Stock	M - Exercise	D		1,1500	5.423	6		7.729
2020-08-24	2020-08-21	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,24		-10.000		148.767
2020-08-24	2020-08-21	4	Mow Jonathan P	PHAS	Common Stock	M - Exercise	D		1,2400	10.000	12		119.243
2020-08-17	2020-08-14	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,69		-5.000		105.582
2020-08-17	2020-08-14	4	Sharp John P	PHAS	Common Stock	M - Exercise	D		1,6900	5.000	8		40.000
2020-06-05	2020-06-03	4	Sapir Alex	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	4,86		4.909		4.909
2020-06-05	2020-06-03	4	Loewy Caroline M	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0,00		16.000		16.000
2020-06-05	2020-06-03	4	HARRIGAN EDMUND	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	4,86		16.000		16.000
2020-06-05	2020-06-03	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	4,86		16.000		16.000
2020-06-05	2020-06-03	4	van den Broek Richard	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	4,86		16.000		16.000
2020-06-05	2020-06-03	4	Klein Peter Justin	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	4,86		16.000		16.000
2020-06-05	2020-06-03	4	Thorp Clay	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	4,86		16.000		16.000
2020-02-14	2020-02-12	4	Burkhardt Glen	PHAS	Employee Stock Option (right to buy)	A - Award	D	5,19		20.000		20.000
2020-02-14	2020-02-12	4	Burkhardt Glen	PHAS	Employee Stock Option (right to buy)	A - Award	D	5,19		55.000		55.000
2020-02-14	2020-02-12	4	York Michael	PHAS	Employee Stock Option (right to buy)	A - Award	D	5,19		55.000		55.000
2020-02-14	2020-02-12	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	A - Award	D	5,19		100.000		100.000
2020-02-14	2020-02-12	4	Hanson Kristopher	PHAS	Employee Stock Option (right to buy)	A - Award	D	5,19		55.000		55.000
2020-02-14	2020-02-12	4	Sapir Alex	PHAS	Employee Stock Option (right to buy)	A - Award	D	5,19		32.000		32.000
2020-02-14	2020-02-12	4	Lee John Sang	PHAS	Employee Stock Option (right to buy)	A - Award	D	5,19		100.000		100.000
2020-02-14	2020-02-12	4	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	A - Award	D	5,19		55.000		55.000
2020-02-14	2020-02-12	4	Ballance David James	PHAS	Employee Stock Option (right to buy)	A - Award	D	5,19		55.000		55.000
2020-02-14	2020-02-12	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	A - Award	D	5,19		290.000		290.000
2019-10-07	2019-10-07	4	Hanson Kristopher	PHAS	Employee Stock Option (right to buy)	A - Award	D	4,17		66.000		66.000
2019-09-10	2019-09-06	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,24		-19.000		158.767
2019-09-10	2019-09-06	4	Mow Jonathan P	PHAS	Common Stock	M - Exercise	D		1,2400	19.000	24		109.243
2019-08-22	2019-08-21	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,44		-5.000		4.038
2019-08-22	2019-08-21	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,69		-10.000		110.582
2019-08-22	2019-08-21	4	Sharp John P	PHAS	Common Stock	M - Exercise	D		1,4400	5.000	7		35.000
2019-08-22	2019-08-21	4	Sharp John P	PHAS	Common Stock	M - Exercise	D		1,6900	10.000	17		30.000
2019-07-03	2019-07-01	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Common Stock	S - Sale	I		14,0000	-459	-6		415.959
2019-07-03	2019-07-01	4	Thorp Clay By Hatteras Venture Partners I, LP	PHAS	Common Stock	S - Sale	I		14,0000	-255	-4		52.397
2019-07-03	2019-07-01	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Common Stock	S - Sale	I		14,0000	-180	-3		162.890
2019-07-03	2019-07-01	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Common Stock	S - Sale	I		14,0000	-2.014	-28		1.818.638
2019-06-20	2019-06-18	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Common Stock	S - Sale	I		14,0000	-63	-1		416.418
2019-06-20	2019-06-18	4	Thorp Clay By Hatteras Venture Partners I, LP	PHAS	Common Stock	S - Sale	I		14,0000	-35	-0		52.655
2019-06-20	2019-06-18	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Common Stock	S - Sale	I		14,0000	-25	-0		163.074
2019-06-20	2019-06-18	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Common Stock	S - Sale	I		14,0000	-277	-4		1.820.656
2019-05-24	2019-05-22	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1,69		-15.000		120.582
2019-05-24	2019-05-22	4	Sharp John P	PHAS	Common Stock	M - Exercise	D		1,6900	15.000	25		20.000
2019-05-21	2019-05-20	4	Mow Jonathan P	PHAS	Employee stock option (right to buy)	M - Exercise	D	1,24		-19.131		0
2019-05-21	2019-05-20	4	Mow Jonathan P	PHAS	Common Stock	M - Exercise	D		1,2400	19.131	24		90.243
2019-05-21	2019-05-17	4	Mow Jonathan P	PHAS	Employee stock option (right to buy)	M - Exercise	D	2,27		-19.913		0
2019-05-21	2019-05-17	4	Mow Jonathan P	PHAS	Common Stock	M - Exercise	D		2,2700	19.913	45		71.112
2019-05-13	2019-05-09	4	Thorp Clay	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13,23		11.000		11.000
2019-05-13	2019-05-09	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13,23		11.000		11.000
2019-05-13	2019-05-09	4	Loewy Caroline M	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13,23		9.167		9.167
2019-05-13	2019-05-09	4	HARRIGAN EDMUND	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13,23		4.583		4.583
2019-05-13	2019-05-09	4	van den Broek Richard	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13,23		2.750		2.750
2019-05-13	2019-05-09	4	Klein Peter Justin	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13,23		11.000		11.000
2019-05-13	2019-05-09	4	Mukhopadhyay Bibhash	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13,23		11.000		11.000
2019-03-01	2019-02-27	4	TUFTS LINDA	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,15		36.000		36.000
2019-03-01	2019-02-27	4	Ballance David James	PHAS	Employee Stock Option (right to buy)	A - Award	D	3,15		45.000		45.000
2019-03-01	2019-02-27	4	Hutson Nancy J	PHAS	Employee Stock Option (right to buy)	A - Award	D	3,15		8.900		8.900
2019-03-01	2019-02-27	4	Klein Peter Justin	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,15		36.000		36.000
2019-03-01	2019-02-27	4	Lee John Sang	PHAS	Employee Stock Option (right to buy)	A - Award	D	3,15		100.000		100.000
2019-03-01	2019-02-27	4	Loewy Caroline M	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,15		8.900		8.900
2019-03-01	2019-02-27	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	A - Award	D	3,15		100.000		100.000
2019-03-01	2019-02-27	4	Thorp Clay	PHAS	Employee Stock Option (right to buy)	A - Award	D	3,15		36.000		36.000
2019-03-01	2019-02-27	4	van den Broek Richard	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,15		23.000		23.000
2019-03-01	2019-02-27	4	van den Broek Richard	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,15		22.000		22.000
2019-03-01	2019-02-27	4	York Michael	PHAS	Employee Stock Option (right to buy)	A - Award	D	3,15		45.000		45.000
2019-03-01	2019-02-27	4	Mukhopadhyay Bibhash	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3,15		36.000		36.000
2019-03-01	2019-02-27	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	A - Award	D	3,15		263.000		263.000
2019-03-01	2019-02-27	4	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	A - Award	D	3,15		45.000		45.000
2018-12-17		3/A	Ballance David James	PHAS	Common Stock		D						6.600
2018-12-17	2018-12-17	4	Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person	PHAS	Common Stock	P - Purchase	I		4,4600	1.000	4		1.000
2018-12-17	2018-12-13	4	Ballance David James	PHAS	Common Stock	P - Purchase	D		3,9400	1.000	4		7.600
2018-12-17	2018-12-13	4	HARRIGAN EDMUND	PHAS	Employee Stock Option (right to buy)	A - Award	D	3,65		68.966		68.966
2018-12-17	2018-12-13	4	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock	P - Purchase	I		3,6900	1.000	4		51.199
2018-12-13	2018-12-10	4/A	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock	P - Purchase	I		3,8500	800	3		50.199
2018-12-13	2018-12-07	4/A	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock	P - Purchase	I		3,8900	700	3		49.399
2018-12-11	2018-12-10	4	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock	P - Purchase	I		3,8500	800	3		51.699
2018-12-11	2018-12-07	4	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock	P - Purchase	I		3,8800	2.200	9		50.899
2018-12-11	2018-12-07	4	Sharp John P	PHAS	Common Stock	P - Purchase	D		3,8400	5.000	19		5.000
2018-12-11	2018-12-11	4	York Michael	PHAS	Common Stock	P - Purchase	D		3,8800	1.500	6		1.500
2018-12-06	2018-12-04	4	Thorp Clay	PHAS	Common Stock	P - Purchase	D		3,1300	4.000	13		15.799
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series D Preferred Stock	C - Conversion	I			-1.124.301		0
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-437.706		0
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series C-1 Preferred Stock	S - Sale	I		5,0000	-4.349	-22	437.706
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series C-1 Preferred Stock	X - Other	I		0,1200	181.190	22	442.055
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Warrants to Purchase Series C-1 Preferred Stock	X - Other	I	0,12		-181.190		0
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series B Preferred Stock	C - Conversion	I			-3.279.627		0
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series B Preferred Stock	S - Sale	I		5,0000	-1.177	-6	3.279.627
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series B Preferred Stock	X - Other	I		0,1200	49.030	6	3.280.804
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Warrants to Purchase Series B Preferred Stock	X - Other	I	0,12		-49.030		0
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Common Stock	P - Purchase	I		5,0000	1.800.000	9.000		6.641.634
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Common Stock	C - Conversion	I			4.841.634			4.841.634
2018-10-24	2018-10-22	4	Klein Peter Justin	PHAS	Series B Preferred Stock	C - Conversion	D			-2.303		0
2018-10-24	2018-10-22	4	Klein Peter Justin	PHAS	Series B Preferred Stock	S - Sale	D		5,0000	-3	-0	2.303
2018-10-24	2018-10-22	4	Klein Peter Justin	PHAS	Series B Preferred Stock	X - Other	D		0,1200	103	0	2.306
2018-10-24	2018-10-22	4	Klein Peter Justin	PHAS	Warrants to Purchase Series B Preferred Stock	X - Other	D	0,12		-103		0
2018-10-24	2018-10-22	4	Klein Peter Justin	PHAS	Common Stock	C - Conversion	D			2.303			2.303
2018-10-24	2018-10-22	4	Arnold Susan Elizabeth	PHAS	Series B Preferred Stock	C - Conversion	D			-2.306		0
2018-10-24	2018-10-22	4	Arnold Susan Elizabeth	PHAS	Series B Preferred Stock	M - Exercise	D		0,1200	103	0	2.306
2018-10-24	2018-10-22	4	Arnold Susan Elizabeth	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	D	0,12		-103		0
2018-10-24	2018-10-22	4	Arnold Susan Elizabeth	PHAS	Common Stock	C - Conversion	D			2.306			2.306
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Series D Preferred Stock	C - Conversion	I			-740.337		0
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-1.664.217		0
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Series C-1 Preferred Stock	S - Sale	I		5,0000	-2.734	-14	1.664.217
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Series C-1 Preferred Stock	X - Other	I		0,1200	113.891	14	1.666.951
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Warrants to Purchase Series C-1 Preferred Stock	X - Other	I	0,12		-113.891		0
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Common Stock	P - Purchase	I		5,0000	600.000	3.000		3.004.554
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Common Stock	C - Conversion	I			2.404.554			2.404.554
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Series D Preferred Stock	C - Conversion	I			-226.061		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-24.709		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-272.107		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-40.420		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-13.558		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-149.320		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-94.874		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-1.044.764		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-13.609		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-174.699		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC	PHAS	Series 1 Preferred Stock	C - Conversion	I			-4.846		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series 1 Preferred Stock	C - Conversion	I			-3.862		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series 1 Preferred Stock	C - Conversion	I			-42.530		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP	PHAS	Series 1 Preferred Stock	C - Conversion	I			-52.690		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Series C-1 Preferred Stock	S - Sale	I		5,0000	-994	-5	40.420
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Series C-1 Preferred Stock	X - Other	I		0,1200	41.414	5	41.414
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Warrants to Purchase Series C-1 Preferred Stock	X - Other	I	0,12		-41.414		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5,0000	-104	-1	13.558
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series C-1 Preferred Stock	X - Other	I		0,1200	4.309	1	13.662
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	X - Other	I	0,12		-4.309		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5,0000	-1.139	-6	149.320
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series C-1 Preferred Stock	X - Other	I		0,1200	47.458	6	150.459
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	X - Other	I	0,12		-47.458		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series B Preferred Stock	S - Sale	I		5,0000	-42	-0	94.874
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series B Preferred Stock	X - Other	I		0,1200	1.731	0	94.916
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Warrants to Purchase Series B Preferred Stock	X - Other	I	0,12		-1.731		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series B Preferred Stock	S - Sale	I		5,0000	-458	-2	1.044.764
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series B Preferred Stock	X - Other	I		0,1200	19.061	2	1.045.222
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Warrants to Purchase Series B Preferred Stock	X - Other	I	0,12		-19.061		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Common Stock	P - Purchase	I		5,0000	150.000	750		416.481
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Common Stock	C - Conversion	I			266.481			266.481
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC	PHAS	Common Stock	C - Conversion	I			4.846			4.846
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Common Stock	P - Purchase	I		5,0000	12.487	62		163.099
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Common Stock	C - Conversion	I			150.612			150.612
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Common Stock	P - Purchase	I		5,0000	137.513	688		1.820.933
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Common Stock	C - Conversion	I			1.683.420			1.683.420
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP	PHAS	Common Stock	C - Conversion	I			52.690			52.690
2018-10-24	2018-10-22	4	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Series B Preferred Stock	C - Conversion	I			-3.505		0
2018-10-24	2018-10-22	4	Mow Jonathan P	PHAS	Series B Preferred Stock	C - Conversion	D			-310		0
2018-10-24	2018-10-22	4	Mow Jonathan P	PHAS	Series B Preferred Stock	M - Exercise	D		0,1200	310	0	310
2018-10-24	2018-10-22	4	Mow Jonathan P	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	D	0,12		-310		0
2018-10-24	2018-10-22	4	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock	C - Conversion	I			3.505			48.699
2018-10-24	2018-10-22	4	Mow Jonathan P	PHAS	Common Stock	C - Conversion	D			310			310
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Series D Preferred Stock	C - Conversion	I			-226.061		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-24.709		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-272.107		0
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-40.420		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-13.558		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-149.320		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-94.874		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-1.044.764		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-13.609		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-174.699		0
2018-10-24	2018-10-22	4	Thorp Clay By Catalysta Ventures, LLC	PHAS	Series 1 Preferred Stock	C - Conversion	I			-4.846		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series 1 Preferred Stock	C - Conversion	I			-3.862		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series 1 Preferred Stock	C - Conversion	I			-42.530		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners I, LP	PHAS	Series 1 Preferred Stock	C - Conversion	I			-52.690		0
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Series C-1 Preferred Stock	S - Sale	I		5,0000	-994	-5	40.420
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Series C-1 Preferred Stock	M - Exercise	I		0,1200	41.414	5	41.414
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Warrants to Purchase Series C-1 Preferred Stock	M - Exercise	I	0,12		-41.414		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5,0000	-104	-1	13.558
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series C-1 Preferred Stock	M - Exercise	I		0,1200	4.309	1	13.662
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	M - Exercise	I	0,12		-4.309		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5,0000	-1.139	-6	149.320
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series C-1 Preferred Stock	M - Exercise	I		0,1200	47.458	6	150.459
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	M - Exercise	I	0,12		-47.458		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series B Preferred Stock	S - Sale	I		5,0000	-42	-0	94.874
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series B Preferred Stock	M - Exercise	I		0,1200	1.731	0	94.916
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	I	0,12		-1.731		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series B Preferred Stock	S - Sale	I		5,0000	-458	-2	1.044.764
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series B Preferred Stock	M - Exercise	I		0,1200	19.061	2	1.045.222
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	I	0,12		-19.061		0
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Common Stock	P - Purchase	I		5,0000	150.000	750		416.481
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Common Stock	C - Conversion	I			266.481			266.481
2018-10-24	2018-10-22	4	Thorp Clay By Catalysta Ventures, LLC	PHAS	Common Stock	C - Conversion	I			4.846			4.846
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Common Stock	P - Purchase	I		5,0000	12.487	62		163.099
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Common Stock	C - Conversion	I			150.612			150.612
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Common Stock	P - Purchase	I		5,0000	137.513	688		1.820.933
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Common Stock	C - Conversion	I			1.683.420			1.683.420
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners I, LP	PHAS	Common Stock	C - Conversion	I			52.690			52.690
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-30.334		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-6.413		0
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-63.688		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-22.452		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-4.746		0
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-47.140		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-165.395		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-34.968		0
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-347.250		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-56.874		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-12.025		0
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-119.408		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5,0000	-113	-1	22.452
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series C-1 Preferred Stock	M - Exercise	I		0,1200	4.690	1	22.565
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	M - Exercise	I	0,12		-4.690		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5,0000	-24	-0	4.746
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series C-1 Preferred Stock	M - Exercise	I		0,1200	991	0	4.770
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	M - Exercise	I	0,12		-991		0
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5,0000	-237	-1	47.140
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series C-1 Preferred Stock	M - Exercise	I		0,1200	9.847	1	47.377
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	M - Exercise	I	0,12		-9.847		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series B Preferred Stock	S - Sale	I		5,0000	-81	-0	165.395
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series B Preferred Stock	M - Exercise	I		0,1200	3.359	0	165.476
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	I	0,12		-3.359		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series B Preferred Stock	S - Sale	I		5,0000	-18	-0	34.968
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series B Preferred Stock	M - Exercise	I		0,1200	710	0	34.986
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	I	0,12		-710		0
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series B Preferred Stock	S - Sale	I		5,0000	-170	-1	347.250
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series B Preferred Stock	M - Exercise	I		0,1200	7.053	1	347.420
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	I	0,12		-7.053		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Common Stock	P - Purchase	I		5,0000	6.041	30		281.096
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Common Stock	C - Conversion	I			275.055			275.055
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Common Stock	P - Purchase	I		5,0000	1.277	6		59.429
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Common Stock	C - Conversion	I			58.152			58.152
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Common Stock	P - Purchase	I		5,0000	12.682	63		590.168
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Common Stock	C - Conversion	I			577.486			577.486
2018-10-17	2018-10-17	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	A - Award	D	5,00		220.000		220.000
2018-10-17		3	Thorp Clay	PHAS	Common Stock		D						23.598
2018-10-17		3	Thorp Clay	PHAS	Common Stock		D						23.598
2018-10-17		3	Thorp Clay	PHAS	Common Stock		D						23.598
2018-10-17		3	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock		I						90.388
2018-10-17		3	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock		I						90.388
2018-10-17		3	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock		I						90.388

Türev olmayan veya türev menkul kıymetlerin açık piyasa veya özel alımı

Türev olmayan veya türev menkul kıymetlerin açık piyasa veya özel satımı

Şirketten menkul kıymetlerin verilmesi, ödüllendirilmesi veya başka şekilde edinilmesi (opsiyon gibi)

Türevin dönüşümü

Menkul kıymetlerin şirkete geri satışı veya devri

Kullanım bedelinin veya vergi yükümlülüğünün şirketten alınan menkul kıymetlerin bir kısmı kullanılarak ödenmesi

Menkul kıymetlerin içeriden birine veya kişiye hediye edilmesi

Özkaynak swapları ve benzeri riskten korunma işlemleri

Şirketten alınan türev menkul kıymetin kullanılması veya dönüştürülmesi (opsiyon gibi)

Form 4te gönüllü olarak bildirilen bir işlem

Diğer (işlemi açıklayan bir dipnotla birlikte)

PHASQ / PhaseBio Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5